At the 2020 Gastrointestinal Cancers Symposium, research highlights include disparities in care among young adults with colorectal cancer, patient-reported outcomes in liver cancer and colorectal cancer, and a blood-based test to find hard-to-detect cancers.
The "Your Stories" podcast series from Conquer Cancer, the ASCO Foundation, provides insight into what it’s like to conquer cancer from different viewpoints. The podcasts featured here touch on how families cope with a cancer diagnosis.
Una sigmoidoscopia es una prueba mediante la cual se observa el recto y la parte inferior del intestino grueso. “Colon” es el término médico que se usa para referirse al intestino grueso y el colon sigmoide es la parte inferior. El colon sigmoide termina en el recto. Los desechos se acumulan en el recto y salen del cuerpo cuando tiene una deposición.
En la ilustración a continuación, se muestran las diferentes partes del colon y el recto.
Angiogenesis inhibitors are a type of cancer treatment. They stop a process in the body called angiogenesis, or blood vessel formation.
Angiogenesis is how the body forms new blood vessels. This is a normal part of growth and healing. But sometimes angiogenesis can play a role in diseases such as cancer.
To grow, a tumor needs nutrients and oxygen from your blood. The tumor sends signals that stimulate more blood vessels to grow and carry more blood.
Being diagnosed with colorectal cancer can be scary and confusing. Dr. Jeffrey Meyerhardt, an expert in colorectal cancer, describes the 4 questions that any newly diagnosed patient should ask.
ASCO and NCCN have worked together to help clinicians and patients identify and treat the side effects of immunotherapy before they become dangerous. Doctor and patient advocate Laura Porter describes what to watch out for if you’re taking an immune checkpoint inhibitor, a type of immunotherapy, for cancer.
Social media can help oncologists share valuable research to improve how they treat patients. Patients can also use social media to improve their own care.
The 2017 Clinical Cancer Advances report of the American Society of Clinical Oncology has announced that the Advance of the Year is Immunotherapy 2.0. Why 2.0? Because the role of immunotherapy in cancer care is expanding, and oncologists are learning how to use it more effectively.
When your “plumbing wears out,” an ostomy bag is a way to live well and regain control of your body, as told by colorectal cancer survivor Melissa Marshall
Genetic testing allows doctors to help treat, and even prevent, certain types of cancers. Many patients can benefit from genetic testing; however, we still don’t know a lot about how to best use the results of these tests.
